26 related articles for article (PubMed ID: 24485306)
1. Nucleolar and spindle associated protein 1 enhances chemoresistance through DNA damage repair pathway in chronic lymphocytic leukemia by binding with RAD51.
Han Y; Hu X; Yun X; Liu J; Yang J; Tian Z; Zhang X; Zhang Y; Wang X
Cell Death Dis; 2021 Nov; 12(11):1083. PubMed ID: 34782617
[TBL] [Abstract][Full Text] [Related]
2. Association of RAD51 and XRCC2 Gene Polymorphisms with Cervical Cancer Risk in the Bangladeshi Women.
Ivy SC; Shabnaz S; Shahriar M; Jafrin S; Aka TD; Aziz MA; Islam MS
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2099-2107. PubMed ID: 34319032
[TBL] [Abstract][Full Text] [Related]
3. Role of DNA Methylation in the Resistance to Therapy in Solid Tumors.
Romero-Garcia S; Prado-Garcia H; Carlos-Reyes A
Front Oncol; 2020; 10():1152. PubMed ID: 32850327
[TBL] [Abstract][Full Text] [Related]
4. Genetic Variations of RAD51 and XRCC2 Genes Increase the Risk of Colorectal Cancer in Bangladeshi Population.
Hridy AU; Shabnaz S; Asaduzzaman MD; Shahriar M; Bhuiyan MA; Islam MS; Hossen SMM; Emran TB
Asian Pac J Cancer Prev; 2020 May; 21(5):1445-1451. PubMed ID: 32458654
[TBL] [Abstract][Full Text] [Related]
5. Radiation biology and oncology in the genomic era.
Kerns SL; Chuang KH; Hall W; Werner Z; Chen Y; Ostrer H; West C; Rosenstein B
Br J Radiol; 2018 Nov; 91(1091):20170949. PubMed ID: 29888979
[TBL] [Abstract][Full Text] [Related]
6. Methylation of TMEM176A is an independent prognostic marker and is involved in human colorectal cancer development.
Gao D; Han Y; Yang Y; Herman JG; Linghu E; Zhan Q; Fuks F; Lu ZJ; Guo M
Epigenetics; 2017 Jul; 12(7):575-583. PubMed ID: 28678648
[TBL] [Abstract][Full Text] [Related]
7. Valproic acid, targets papillary thyroid cancer through inhibition of c-Met signalling pathway.
Fu YT; Zheng HB; Zhou L; Zhang DQ; Liu XL; Sun H
Am J Transl Res; 2017; 9(6):3138-3147. PubMed ID: 28670399
[TBL] [Abstract][Full Text] [Related]
8. The homologous recombination protein RAD51 is a promising therapeutic target for cervical carcinoma.
Chen Q; Cai D; Li M; Wu X
Oncol Rep; 2017 Aug; 38(2):767-774. PubMed ID: 28627709
[TBL] [Abstract][Full Text] [Related]
9. Radiogenomics: A systems biology approach to understanding genetic risk factors for radiotherapy toxicity?
Herskind C; Talbot CJ; Kerns SL; Veldwijk MR; Rosenstein BS; West CM
Cancer Lett; 2016 Nov; 382(1):95-109. PubMed ID: 26944314
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the novel tumor-suppressor gene CCDC67 in papillary thyroid carcinoma.
Yin DT; Xu J; Lei M; Li H; Wang Y; Liu Z; Zhou Y; Xing M
Oncotarget; 2016 Feb; 7(5):5830-41. PubMed ID: 26716505
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of homologous recombination RAD51, RAD51B, XRCC2, and XRCC3 genes and the risk of prostate cancer.
Nowacka-Zawisza M; Wiśnik E; Wasilewski A; Skowrońska M; Forma E; Bryś M; Różański W; Krajewska WM
Anal Cell Pathol (Amst); 2015; 2015():828646. PubMed ID: 26339569
[TBL] [Abstract][Full Text] [Related]
12. XRCC2 as a predictive biomarker for radioresistance in locally advanced rectal cancer patients undergoing preoperative radiotherapy.
Qin CJ; Song XM; Chen ZH; Ren XQ; Xu KW; Jing H; He YL
Oncotarget; 2015 Oct; 6(31):32193-204. PubMed ID: 26320178
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic Alteration by DNA Methylation of ESR1, MYOD1 and hTERT Gene Promoters is Useful for Prediction of Response in Patients of Locally Advanced Invasive Cervical Carcinoma Treated by Chemoradiation.
Sood S; Patel FD; Ghosh S; Arora A; Dhaliwal LK; Srinivasan R
Clin Oncol (R Coll Radiol); 2015 Dec; 27(12):720-7. PubMed ID: 26344356
[TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation of p73 and p53 genes in cervical cancer patients among north Indian population.
Jha AK; Nikbakht M; Jain V; Sehgal A; Capalash N; Kaur J
Mol Biol Rep; 2012 Sep; 39(9):9145-57. PubMed ID: 22729911
[TBL] [Abstract][Full Text] [Related]
15. Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer.
Lando M; Fjeldbo CS; Wilting SM; C Snoek B; Aarnes EK; Forsberg MF; Kristensen GB; Steenbergen RD; Lyng H
Epigenetics; 2015; 10(10):970-80. PubMed ID: 26291246
[TBL] [Abstract][Full Text] [Related]
16. [Correlation between DNA Methylation of ZNF772 Promoter Region and Cervical Cancer].
Li M; Li O; Sun J; Zheng X; Ma D
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Apr; 42(2):164-171. PubMed ID: 32385021
[No Abstract] [Full Text] [Related]
17. ATM and TGFB1 genes polymorphisms in prediction of late complications of chemoradiotherapy in patients with locally advanced cervical cancer.
Paulikova S; Petera J; Sirak I; Vosmik M; Drastikova M; Dusek L; Cvanova M; Soumarova R; Spacek J; Beranek M
Neoplasma; 2014; 61(1):70-6. PubMed ID: 24195511
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of RAD51L3 and XRCC2 genes to predict late toxicity in chemoradiotherapy-treated cervical cancer patients.
Paulíková S; Chmelařová M; Petera J; Palička V; Paulík A
Folia Biol (Praha); 2013; 59(6):240-5. PubMed ID: 24485306
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
